Data / Form D filings / AmideBio, LLC
AmideBio, LLC: Form D filings
AmideBio, LLC, a biotechnology company in Boulder, CO, filed 9 Form D notices with the SEC between 2010 and 2017. The latest, on November 6, 2017, reports $763,517 sold of a $763,517 offering to 9 investors.
Find out what AmideBio, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2830 13TH STREET, Boulder, CO, 80304
- Phone
- (303) 641-3669
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1483408
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | New notice | $763,517 | $763,517 | $0 | 9 | Oct 24, 2017 | sec.gov |
| Apr 12, 2017 | Amendment | $768,000 | $396,000 | $372,000 | 9 | Apr 7, 2016 | sec.gov |
| Dec 29, 2016 | Amendment | $768,000 | $348,000 | $420,000 | 8 | Apr 7, 2016 | sec.gov |
| Apr 13, 2016 | New notice | $216,000 | $144,000 | $72,000 | 3 | Apr 7, 2016 | sec.gov |
| Jan 13, 2015 | New notice | $1,079,287 | $279,287 | $800,000 | 5 | Dec 31, 2014 | sec.gov |
| May 7, 2014 | New notice | $750,000 | $400,000 | $350,000 | 4 | Dec 18, 2013 | sec.gov |
| May 25, 2012 | New notice | $750,000 | $300,000 | $450,000 | 6 | May 15, 2012 | sec.gov |
| May 9, 2011 | New notice | $575,000 | $575,000 | $0 | 5 | Dec 21, 2010 | sec.gov |
| Feb 4, 2010 | New notice | $274,997 | $274,997 | $0 | 2 | Jan 21, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ruel C. Mercure | Director | |
| David P. Brunel | Director | |
| Niles C. Utlaut | Director | |
| Gregory C. Abbott | Director | |
| David C. Barker | Director | |
| Michael H.B. Stowell | Executive Officer, Director | |
| Mikhail Plam | Executive Officer, Director | |
| Vincent P. Mihalik | Director |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Nov 6, 2017 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AmideBio, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.